Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23201781 | 0.93 | MAPK14 (1.00) | MAPK14MAPK13 | |
| SCHEMBL23201660 | 0.90 | MAPK14 (0.79) | MAPK14MAPK13 | |
| SCHEMBL23637702 | 0.89 | MAPK14 (1.00) | MAPK14MAPK13 | |
| SCHEMBL23201695 | 0.88 | MAPK14 (1.00) | MAPK14MAPK13 | |
| SCHEMBL23201762 | 0.88 | MAPK14 (1.00) | MAPK14MAPK13 | |
| SCHEMBL23201709 | 0.86 | MAPK14 (0.80) | MAPK14MAPK13 | |
| SCHEMBL23201903 | 0.78 | MAPK14 (1.00) | MAPK14MAPK13 | |
| SCHEMBL30500560 | 0.78 | MAPK14 (1.00) | MAPK14MAPK13 | |
| SCHEMBL23201826 | 0.76 | MAPK14 (0.85) | MAPK14MAPK13 | |
| SCHEMBL29844470 | 0.76 | MAPK14 (0.85) | MAPK14MAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4219489-A2 | MITOGEN-ACTIVATED PROTEIN KINASE INHIBITORS, METHODS OF MAKING, AND METHODS OF USE THEREOF | Washington University (US) | 2023-08-02 | — | — | EP | disclosed |